Citizens Maintains Market Outperform on enGene Holdings, Raises Price Target to $21
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
Citizens analyst Silvan Tuerkcan maintains enGene Holdings (NASDAQ:ENGN) with a Market Outperform and raises the price target from $18 to $21.
Citizens analyst Silvan Tuerkcan maintains enGene Holdings (NASDAQ:ENGN) with a Market Outperform and raises the price target from $18 to $21.